Items Tagged ‘immunotherapy’
February 7, 2019
Eva Galanis, M.D.-Bitten by the virotherapy bug
By Advancing the Science contributor 
Every day more than 1,600 Americans die from cancer. Most of them have cancer that can’t be cured with traditional methods — surgery, radiation and chemotherapy. The father of Evanthia Galanis, M.D., was one of them. He died in the late 1990s from melanoma when his daughter was a junior faculty member at Mayo Clinic. “My father would have […]
Tags: basic science, cancer, clinical trials, Eva Galanis, gene therapy, hematology, immunotherapy, Mayo Clinic Cancer Center, measles virus, oncology, SPORE, virotherapy
January 3, 2019
A vaccine to prevent breast cancer? It’s worth a shot
By Advancing the Science contributor
Each fall, millions of Americans roll up their sleeves for a flu shot, grateful for the quick pinch that may save them from the misery the flu can bring. In the not-too-distant future, there may be a poke with a much bigger payout. Scientists at Mayo Clinic and elsewhere are working on vaccines that could […]
Tags: breast cancer, immunotherapy, Keith Knutson, Mayo Clinic Cancer Center, ovarian cancer
August 23, 2018
Using the body to recognize and attack cancer
This article originally appeared in the Center for Individualized Medicine blog on July 23, 2018 For as long as he can remember, Saad Kenderian, M.B., Ch.B., wanted to be a physician. Nothing could blunt his resolve –not even when improvised explosive devices, bombs and trappings of war put the medical school in his native Baghdad, […]
Tags: cancer, CAR-T, Center for Individualized Medicine, gene therapy, immunotherapy, Mayo Clinic Cancer Center, Saad Kenderian
July 25, 2018
Advances in lung cancer immunotherapy and management of immune-mediated adverse events
By Advancing the Science contributor
Over the last few years, immunotherapy using immune checkpoint inhibitors targeting programmed cell death receptor 1 (PD-1) or programmed cell death receptor ligand 1 (PD-L1) has revolutionized the therapeutic approach to advanced-stage non-small cell lung cancer and numerous other malignancies. Monotherapy, using the anti-PD-1 antibody pembrolizumab, is now Food and Drug Administration (FDA) approved for […]
Tags: clinical trials, immunotherapy, lung cancer, Mayo Clinic Cancer Center, measles virus
July 12, 2018
Arresting melanoma’s molecular drivers
This post originally appeared on the Center for Individualized Medicine blog on May 15, 2018. Article by Barbara Toman Melanoma, the skin cancer often associated with sun exposure, is on the rise and has no reliable cure. Mayo Clinic is at the forefront of efforts aimed at increasing early detection and treatment of this aggressive disease. The […]
Tags: Aleksander Sekulic, cancer, Center for Individualized Medicine, gene mutation, immunotherapy, Mayo Clinic Cancer Center, Mayo Clinic Laboratories, melanoma, Minetta Liu
June 6, 2017
Meet the researchers – Sandra J. Gendler, Ph.D. & Peter A. Cohen, M.D.: The Dynamic Duo
On the brink of discovery, Sandra J. Gendler, Ph.D., and Peter A. Cohen, M.D., take a moment to reflect on a collaboration and friendship that began in 2008 when Dr. Cohen made the move to Mayo Clinic in Arizona. “I recognized that this chance to work closely with Sandy offered a once-in-a-lifetime opportunity to figure […]
Tags: cancer, clinical trials, Forefront, immunotherapy, Mayo Clinic Cancer Center
April 18, 2017
Attack the Gap-New Immunotherapy May Help the Body Fight Ovarian Cancer
It was only when Kathi Schroeder took to the bone-chilling streets of Cedar Rapids, Iowa, on her bike last January that she noticed something was not right. “I was having trouble breathing; just taking a deep breath was difficult,” she remembers. Kathi went to her local doctor’s office and was prescribed a round of antibiotics […]
Tags: clinical trials, immunotherapy, Matthew Block, Mayo Clinic Cancer Center, ovarian cancer
September 13, 2016
What is stopping patients from enrolling in clinical trials?
Clinical trials are the mechanism through which new and promising therapies for safe, effective cancer treatment ultimately become available. Not only do trials help identify new or best-practice therapeutic treatment options, but the act of participating in a trial has been shown to actually improve survival. One of the most promising areas of research to […]
Tags: Carmen Radecki Breitkopf, Center for the Science of Health Care Delivery, clinical trials, immunotherapy, measles virus, ovarian cancer